Form 4: Imunon Inc. Insider Trades: Lindborg Acquires Stock
Statement of Changes in Beneficial Ownership
Stacy Lindborg, President and CEO of Imunon, Inc., acquired 2,534 shares of common stock on July 2, 2026, valued at $1.91 per share, as part of her compensation.
Summary
- Stacy Lindborg, President and CEO of Imunon, Inc., acquired 2,534 shares of common stock on July 2, 2026.
- The acquisition was made at a price of $1.91 per share.
- These shares were granted in lieu of cash for a portion of her base salary.
- Following this transaction, Lindborg beneficially owns 76,722 shares of common stock, with 778 shares held indirectly through a 401(k) plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents an insider acquiring stock as part of compensation, which can signal confidence but does not represent new investment or a change in strategic direction.
Positives
- Insider acquisition of stock by the President and CEO can signal confidence in the company's future prospects.
- The acquisition is part of executive compensation, indicating a commitment to aligning executive interests with shareholder value.
Future Outlook
No specific forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that insider stock acquisitions, particularly by senior executives, are common in the biotechnology and pharmaceutical sectors as a method of compensation and to demonstrate commitment. This transaction aligns with typical practices for aligning executive incentives with company performance.
Related Party Transactions
- Acquisition of 2,534 shares of common stock by Stacy Lindborg, President and CEO, in lieu of cash for a portion of her base salary.
Stakeholder Impact
- Shareholders: The acquisition by the CEO as compensation may be viewed positively as it aligns executive interests with the company's performance, though it does not represent new capital investment.
Key Dates
| Date | Description |
|---|---|
| 07/02/2026 | Transaction date for the acquisition of common stock by Stacy Lindborg. |
| 07/07/2026 | Date of signature for the Form 4 filing. |
Keywords
Imunon Inc., IMNN, Form 4, Insider Trading, Stock Acquisition, Executive Compensation, Stacy Lindborg
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.